Shalby Limited has announced the strategic discontinuation of SOCE operations at two of its facilities, while maintaining essential healthcare services through continued OPD operations. The company communicated this decision to stock exchanges as part of its regulatory disclosure obligations.

Operational Changes at Key Facilities

The healthcare provider has decided to discontinue SOCE operations at its Rajkot and Lucknow facilities with specific timelines for each location.

Service Continuity Framework

Despite the discontinuation of SOCE operations, Shalby Limited has assured stakeholders that OPD services will remain fully operational at both Rajkot and Lucknow locations. This approach ensures that patients in these cities will continue to have access to outpatient medical services and consultations.

The company's management decision reflects a strategic restructuring of service offerings while maintaining essential healthcare access points for patients in both cities.

Regulatory Compliance

Shalby Limited filed this intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The disclosure was signed by Tushar Shah, AVP & Company Secretary, and submitted to both NSE and BSE on January 31, 2026.

The announcement demonstrates the company's commitment to transparent communication with stakeholders regarding operational changes that may impact its business structure and service delivery model.

Shalby Limited has informed stock exchanges about the exercise of employee stock options under its Employee Stock Options Scheme 2021. On January 20, 2026, an eligible employee exercised 1,000 stock options, with the Shalby Limited Employee Welfare Trust processing the transfer of equivalent equity shares to the option grantee.

Stock Option Exercise Details

The exercise of options was conducted under the regulatory framework of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015. The company has provided comprehensive details of the transaction to both NSE and BSE exchanges.

ESOP Scheme Framework

The Employee Stock Options Scheme 2021 operates under the administration of the Nomination and Remuneration Committee. The scheme originally granted 48,000 options on July 12, 2023, to eligible employees, with the exercise price determined by the NRC Committee at ₹10.00 per option.

Financial Impact

The exercise of these stock options will not result in any change to the company's paid-up equity share capital, as the shares are being channelized through the secondary market. The ₹10,000.00 realized from the option exercise will be credited to the Shalby Limited Employees Welfare Trust.

The company reported diluted earnings per share of ₹0.68 based on financials for the quarter ended September 30, 2025. The granted options, once vested, entitle option holders to acquire an equal number of equity shares upon payment of the exercise price and applicable taxes in accordance with the scheme's terms and conditions.

Regulatory Compliance

The ESOP scheme operates in compliance with SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021. Under the scheme structure, all vested options must be exercised in a single tranche within one year from the vesting date. The current exercise represents a portion of the 30,000 options that vested on July 12, 2025, leaving eligible employees with remaining time until July 11, 2026, to exercise their vested options.